Skip to Content
You are currently on the new version of our website. Access the old version .
BiologyBiology
  • Editor’s Choice
  • Review
  • Open Access

12 September 2024

26 Pages

From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders

and
School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Repair and Regeneration of Skeletal Muscle

Simple Summary

Neurodegenerative diseases (NDs), like amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), mainly impact the central nervous system, resulting in neuronal death and motor/cognitive impairments. However, recent studies have also shown a significant role of muscle tissue in the pathogenesis of these disorders, suggesting that pathological processes may co-exist in both the brain and muscle tissue. Understanding muscle involvement in NDs can provide novel therapeutic targets for developing more effective treatments for patients affected by NDs.

Abstract

Neurodegenerative diseases (NDs), like amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), primarily affect the central nervous system, leading to progressive neuronal loss and motor and cognitive dysfunction. However, recent studies have revealed that muscle tissue also plays a significant role in these diseases. ALS is characterized by severe muscle wasting as a result of motor neuron degeneration, as well as alterations in gene expression, protein aggregation, and oxidative stress. Muscle atrophy and mitochondrial dysfunction are also observed in AD, which may exacerbate cognitive decline due to systemic metabolic dysregulation. PD patients exhibit muscle fiber atrophy, altered muscle composition, and α-synuclein aggregation within muscle cells, contributing to motor symptoms and disease progression. Systemic inflammation and impaired protein degradation pathways are common among these disorders, highlighting muscle tissue as a key player in disease progression. Understanding these muscle-related changes offers potential therapeutic avenues, such as targeting mitochondrial function, reducing inflammation, and promoting muscle regeneration with exercise and pharmacological interventions. This review emphasizes the importance of considering an integrative approach to neurodegenerative disease research, considering both central and peripheral pathological mechanisms, in order to develop more effective treatments and improve patient outcomes.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.